Clinical analysis of prostate cancer patients with metastatic lesions who had a serum PSA level of less than 10 ng/ml

N. Sakamoto, H. Koga, M. Nakashima, A. Yokomizo, M. Tanaka, S. Naito

Research output: Contribution to journalArticle

Abstract

We analysed the clinical characteristics of prostate cancer patients with metastatic lesions who had a serum PSA level of less than 10 ng/ml. There were four such patients among 197 newly diagnosed prostate cancer patients (2.0%) and among 44 prostate cancer patients with a serum PSA level of less than 10 ng/ml (9.1%). All the patients had Gleason grade 4 or 5 components in needle biopsy specimens and local advanced disease in TRUS and/or MRI. Endocrine therapies were not effective in 3 patients initially. Clinical evaluation of metastatic lesions is needed even in prostate cancer patients with a serum PSA level of less than 10 ng/ml, particularly in the case of those patients with poorly differentiated components and/or local advanced disease.

Original languageEnglish
Pages (from-to)417-420
Number of pages4
JournalNishinihon Journal of Urology
Volume63
Issue number7
Publication statusPublished - Jan 1 2001

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint Dive into the research topics of 'Clinical analysis of prostate cancer patients with metastatic lesions who had a serum PSA level of less than 10 ng/ml'. Together they form a unique fingerprint.

  • Cite this

    Sakamoto, N., Koga, H., Nakashima, M., Yokomizo, A., Tanaka, M., & Naito, S. (2001). Clinical analysis of prostate cancer patients with metastatic lesions who had a serum PSA level of less than 10 ng/ml. Nishinihon Journal of Urology, 63(7), 417-420.